EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Renal Cell Carcinoma

Andreea Ioana Parosanu, Cristina Florina Pirlog, Cristina Orlov Slavu, Ioana Miruna Stanciu, Horia-Teodor Cotan, Radu Constantin Vrabie, Ana-Maria Popa, Mihaela Olaru, Cristian Iaciu, Lucian Ioan Bratu, Ionut Florian Baicoianu, Oana Moldoveanu und 2 weitere

Current Oncology · 2023

DOI: 10.3390/curroncol30020187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, 2023. Verfasst von Andreea Ioana Parosanu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Elias Emergency University Hospital, 011461 Bucharest, Romania. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metastatic renal cell carcinoma (mRCC) is an aggressive cancer characterised by an increased recurrence rate and an inadequate response to treatment. This study aimed to investigate the importance of the neutrophil-to-lymphocyte ratio (NLR) as a prognostic marker for long-term survival in patients with mRCC.

Methods

We retrospectively analysed data from 74 patients with mRCC treated at our medical centre with tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs). We evaluated the predictive value of NLR for overall survival (OS) in these patients.

Results

The median OS was 5.1 months in the higher NLR group (≥3) and 13.3 months in the lower NLR group (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsHumansPrognosisRetrospective StudiesNeutrophilsLymphocytes

Stichwörter der Autor:innen

IMDCMSKCCNLRmetastaticrenal cell carcinoma

Autor:innen und Institutionen

  • Department of Medical Oncology, Elias Emergency University Hospital, 011461 Bucharest, Romania.
  • Department of Oncology, Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  • Department of Urology, Fundeni Clinical Institute, 022328 Bucharest, Romania.
  • Department of Urology, Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.

Zitieren

APA

Parosanu, A. I., Pirlog, C. F., Slavu, C. O., Stanciu, I. M., Cotan, H. T., Vrabie, R. C., Popa, A. M., Olaru, M., Iaciu, C., Bratu, L. I., Baicoianu, I. F., Moldoveanu, O., Baston, C., & Nițipir, C. (2023). The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Renal Cell Carcinoma. Current Oncology. https://doi.org/10.3390/curroncol30020187

Vancouver

Parosanu AI, Pirlog CF, Slavu CO, Stanciu IM, Cotan HT, Vrabie RC, et al. The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Renal Cell Carcinoma. Current Oncology. 2023. doi:10.3390/curroncol30020187

BibTeX
@article{Parosanu2023,
  author = {Parosanu, Andreea Ioana and Pirlog, Cristina Florina and Slavu, Cristina Orlov and Stanciu, Ioana Miruna and Cotan, Horia-Teodor and Vrabie, Radu Constantin and Popa, Ana-Maria and Olaru, Mihaela and Iaciu, Cristian and Bratu, Lucian Ioan and Baicoianu, Ionut Florian and Moldoveanu, Oana and Baston, Catalin and Nițipir, Cornelia},
  title = {The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Renal Cell Carcinoma},
  journal = {Current Oncology},
  year = {2023},
  doi = {10.3390/curroncol30020187}
}
Kostenlos starten →